Skip to main content

Table 1 Clinical and pathological data

From: Pancreatic cancer: Surgery is a feasible therapeutic option for elderly patients

  All patients
N = 460
<70 years
N = 294
≥70 years
N = 166
P value
Age, years, median (range) 65 (19-87) 55 (19-69) 75 (70-87) <0.0001
Gender     
Male (%) 214 (47%) 150 (51%) 64 (39%) 0.01
Female (%) 246 (53%) 144 (49%) 102 (61%)  
ASA* score     
1/2 195 (42%) 156 (53%) 39 (24%) 0.002
≥ 3 246 (53%) 126 (43%) 120 (72%)  
Unknown 19 (5%) 12 (4%) 7 (4%)  
Second primary cancer (per history) 51 (11%) 25 (9%) 26 (16%) 0.02
Jaundice 160 (35%) 83 (28%) 77 (46%) <0.0001
Diagnostic evaluation     
Tomography 443 (96%) 285 (97%) 158 (95%) 0.5
Ultrasound 149 (32%) 99 (34%) 50 (30%) 0.37
Endoscopic ultrasound 291 (63%) 197 (67%) 94 (67%) 0.73
ERCP** 140 (30%) 85 (29%) 55 (33%) 0.21
Preoperative anemia (Hgb < 11 g/dL) 38 (8%) 17 (6%) 21 (13%) 0.12
Tumor site     
Head 297 (65%) 173 (59%) 124 (73%) 0.004
Body/tail 163 (35%) 121 (41%) 42 (27%)  
Invasive cancer 293 (64%) 173 (59%) 121 (73%) 0.002
Histology     
Ductal adenocarcinoma 180 (39%) 105 (36%) 75 (45%) 0.2
Papillary carcinoma 44 (10%) 24 (8%) 20 (12%) 0.41
Cholangiocarcinoma 20 (4%) 14 (5%) 6 (4%) 0.38
IPMN 47(10%) 25 (9%) 22 (13%) 0.16
MCN 53 (12%) 35 (12%) 18 (11%) 0.36
NET 33 (7%) 28 (10%) 5 (3%) 0.009
Others 83 (18%) 63 (20%) 20 (12%) 0.1
  1. * ASA- American society of anesthesiologists; ** ERCP- Endoscopic retrograde cholangiopancreatography